5,000
Participants
Start Date
March 20, 2023
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2025
Collaborators (1)
CSPC-NBP Pharmaceutical Co., Ltd.
INDUSTRY
Peking Union Medical College Hospital
OTHER